Dr. Filip Janku, MD, PhD

Dr. Filip Janku, MD, PhD

Dr. Filip Janku, MD, PhD

Dr. Filip Janku, MD, PhD is an Assistant Professor in the Department of Investigational Cancer Therapeutics (Phase I Program) at MD Anderson Cancer Center. Dr. Janku is a principal investigator for numerous phase I protocols, most of which involve novel, targeted agents, some of those being first-in-human studies. Dr. Janku received multiple awards for his research efforts, including four Merit Awards from ASCO as well as an American Association for Cancer Research Scholar-in-Training Award. Dr. Janku has published over 40 articles in highly-respected, peer-reviewed journals. Dr. Janku's academic research interests focus on poof-of-concept clinical trials that possess a pivotal correlative component especially those involving autophagy, the PI3K/AKT/mTOR pathway and tumor molecular profiling.

Connect With Us
Join other physicians who are receiving our updates.
We hate spam. Your email address will not be sold or shared with anyone else.